Limb-girdle muscular dystrophy
Last updated 12 Dec 2025
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The limb-girdle muscular dystrophies are a group of diseases that cause muscle weakness (myopathy) and wasting (atrophy). The muscles that are most affected are those closest to the center of the body (proximal muscles), specifically the muscles of the shoulders, upper arms, hips, and thighs. Signs and symptoms may appear as early as childhood and typically worsen over time.
Video picks for Genetic conditionsVideo library
Description
The limb-girdle muscular dystrophies are a group of diseases that cause muscle weakness (myopathy) and wasting (atrophy). The muscles that are most affected are those closest to the center of the body (proximal muscles), specifically the muscles of the shoulders, upper arms, hips, and thighs. Signs and symptoms may appear as early as childhood and typically worsen over time.
The severity, age of onset, and specific features of limb-girdle muscle dystrophy vary among affected individuals, even among members of the same family.
In the early stages of limb-girdle muscular dystrophy, affected individuals may have an unusual walking gait, such as waddling or walking on the balls of their feet. Walking this way for an extended period of time can cause overgrowth (hypertrophy) of the calf muscles. Affected individuals may also have difficulty running. They may need to use their arms to push themselves up from a squatting position because of their weak thigh muscles. Over time, as myopathy and atrophy worsen, people with limb-girdle muscular dystrophy may require wheelchair assistance.
Muscle atrophy may cause changes in posture or in the appearance of the shoulders, back, and arms. In particular, weak shoulder muscles tend to make the shoulder blades (scapulae) "stick out" from the back, a sign known as scapular winging. Weak back muscles may also cause an affected individual to have an abnormally curved lower back (lordosis) or a spine that curves to the side (scoliosis). Some affected individuals develop joint stiffness (contractures) that can restrict movement in their hips, knees, ankles, or elbows.
A weakening of the heart muscle (cardiomyopathy) occurs in some people with limb-girdle muscular dystrophy. If the weakness affects the muscles needed for breathing, affected individuals may have mild to severe breathing problems. In some cases, affected individuals need a machine to help them breathe (mechanical ventilation).
Intelligence is generally not affected in people with limb-girdle muscular dystrophy. However, developmental delays and intellectual disabilities have been reported in some affected individuals who have signs and symptoms that are more severe or that appear earlier in life.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant; Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
LGMD
Limb-girdle syndrome
Myopathic limb-girdle syndrome
Patient picks for Genetic conditions

Bones, joints and muscles
Muscular dystrophy
Muscular dystrophy is an inherited (genetic) disorder causing muscle weakness. There are different types of muscular dystrophy, which vary as to how severe they are, ranging from very mild to severe. The different types also vary as to what age they begin. If muscular dystrophy is suspected, tests can help to make an accurate diagnosis. Other people in the family can also be tested to see if they have a muscular dystrophy gene. Muscular dystrophy cannot be cured but there are various treatments which can help.
by Dr Doug McKechnie, MRCGP

Bones, joints and muscles
Muscle weakness
This leaflet looks at types of muscle weakness and discusses the wide range of problems which can cause them. Some of these causes are very common and others are very rare. Some are mild and reversible; others are not. Most can be improved by exercise and physiotherapy.
by Dr Philippa Vincent, MRCGP

Brain and nerves
Motor neurone disease
Motor neurone disease (MND) is a neurological condition that causes a progressive weakness and wasting of many of the muscles in the body. There are various types of motor neurone disease. This leaflet is mainly about amyotrophic lateral sclerosis (ALS), which is the most common type of motor neurone disease. Although there is no cure for motor neurone disease, treatments can help to ease symptoms and disability.
by Dr Rachel Hudson, MRCGP

Brain and nerves
Guillain-Barré syndrome
Guillain-Barré syndrome affects the nerves of the limbs and body and is usually triggered by an infection. The main symptom is sudden onset weakness of the muscles that are supplied by the affected nerves. It requires immediate hospital admission as it can rapidly become very serious. With appropriate treatment and monitoring, most people make a full recovery.
by Dr Colin Tidy, MRCGP

Brain and nerves
Are new treatments for MS on the horizon?
130,000 people in the UK are living with multiple sclerosis (MS). Though there are treatments which can ease and help to manage symptoms, MS is a condition which has no cure. But now, a groundbreaking trial is trying to find new treatments which could revolutionise care for people with MS.
by Ellie Broughton

Brain and nerves
How MS can affect mental health
More than 100,000 people in the UK are estimated to have multiple sclerosis, a lifelong condition which impacts the central nervous system, causing problems with mobility, vision, coordination and sensation. Although the symptoms are physical - such as fatigue, difficulty walking, blurred vision and problems with thinking, learning and planning - MS can have a serious impact on mental health too.
by Lydia Smith
Related patient information and medicines

Patient information leaflet
Muscular dystrophy
Muscular dystrophy is an inherited (genetic) disorder causing muscle weakness. Muscular dystrophy (MD) is the name given to a group of disorders which cause progressive muscle weakness (meaning it gets worse over time). Rarely, women or girls with the Becker gene may have muscle weakness... Limb-girdle muscular dystrophy (LGMD) LGMDs cause.

Patient information leaflet
Muscle weakness
When this kind of weakness occurs, the muscles are often floppier than usual and are reduced in bulkiness. It is also seen in a condition called muscular dystrophy Muscular dystrophy (discussed further below). Both of these conditions result in weakened muscles which cannot move the u... They are rare disorders but the best known and most common.

Patient information leaflet
Ehlers-Danlos syndrome
The Ehlers-Danlos syndromes (EDS) are a group of conditions that affect the stretchiness and strength of supporting tissues in the body, including skin, joints, blood vessels and internal organs. They vary in their impact from very mild through to very severe. What are the Ehlers-Danlos syndromes. The Ehlers Danlos syndromes (EDS) are a group of.

Patient information leaflet
Genetic testing
Note : the information below is a general guide only. It can identify changes in the number of chromosomes ( for example, Down's syndrome Down's syndrome in wh... Fluorescent in situ hybridisation (FISH) analysis - this test looks at certain parts of the chromosomes and can detect very small pieces of chromosomes that are either missing or extra (.

Patient information leaflet
Flat feet and fallen arches
Conditions affecting the joints and soft tis... Some conditions affecting the nerves such as cerebral palsy Cerebral palsy , Parkinson's disease Parkinson's disease and muscular dystrophy Duchenne muscular dystrophy , in which muscles become stiffer and weaker over time. Other causes of flat feet Flat feet are more likely to develop in people.

Patient information leaflet
Metatarsalgia
It happens because of an imbalance in the muscles of the foot. Pes cavus can run in families but it can also happen out of the blue. Most people with pes cavus also have a neurological problem such as cerebral palsy, spina bifida, muscular dystrophy Muscular dystrophy or polio. Pes cavus can mean that extra stress is placed on the ball of the.
Further reading and references
- Limb-girdle muscular dystrophy; MedlinePlus, National Library of Medicine.
- Angelini C, Giaretta L, Marozzo R. An update on diagnostic options and considerations in limb-girdle dystrophies. Expert Rev Neurother. 2018 Sep;18(9):693-703. doi: 10.1080/14737175.2018.1508997. Epub 2018 Aug 21.
- Angelini C. Calpainopathy. 2005 May 10 [updated 2025 May 1]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1313/
- Aoki M, Takahashi T. Dysferlinopathy. 2004 Feb 5 [updated 2025 Dec 4]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1303/
- Bouchard C, Tremblay JP. Limb-Girdle Muscular Dystrophies Classification and Therapies. J Clin Med. 2023 Jul 19;12(14):4769. doi: 10.3390/jcm12144769.
- Chu ML, Moran E. The Limb-Girdle Muscular Dystrophies: Is Treatment on the Horizon? Neurotherapeutics. 2018 Oct;15(4):849-862. doi: 10.1007/s13311-018-0648-x.
- Khadilkar SV, Patel BA, Lalkaka JA. Making sense of the clinical spectrum of limb girdle muscular dystrophies. Pract Neurol. 2018 Jun;18(3):201-210. doi: 10.1136/practneurol-2017-001799. Epub 2018 Feb 22.
- Liewluck T, Milone M. Untangling the complexity of limb-girdle muscular dystrophies. Muscle Nerve. 2018 Aug;58(2):167-177. doi: 10.1002/mus.26077. Epub 2018 Feb 7.
- Liu W, Pajusalu S, Lake NJ, Zhou G, Ioannidis N, Mittal P, Johnson NE, Weihl CC, Williams BA, Albrecht DE, Rufibach LE, Lek M. Estimating prevalence for limb-girdle muscular dystrophy based on public sequencing databases. Genet Med. 2019 Nov;21(11):2512-2520. doi: 10.1038/s41436-019-0544-8. Epub 2019 May 20.
- Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, Jette N. A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies. Can J Neurol Sci. 2016 Jan;43(1):163-77. doi: 10.1017/cjn.2015.311.
- Mitsuhashi S, Kang PB. Update on the genetics of limb girdle muscular dystrophy. Semin Pediatr Neurol. 2012 Dec;19(4):211-8. doi: 10.1016/j.spen.2012.09.008.
- Mohan S, McNulty S, Thaxton C, Elnagheeb M, Owens E, Flowers M, Nunnery T, Self A, Palus B, Gorokhova S, Kennedy A, Niu Z, Johari M, Maiga AB, Macalalad K, Clause AR, Beckmann JS, Bronicki L, Cooper ST, Ganesh VS, Kang PB, Kesari A, Lek M, Levy J, Rufibach L, Savarese M, Spencer MJ, Straub V, Tasca G, Weihl CC. Expert panel curation of 31 genes in relation to limb girdle muscular dystrophy. Ann Clin Transl Neurol. 2024 Sep;11(9):2268-2276. doi: 10.1002/acn3.52127. Epub 2024 Aug 30.
- Nallamilli BRR, Chakravorty S, Kesari A, Tanner A, Ankala A, Schneider T, da Silva C, Beadling R, Alexander JJ, Askree SH, Whitt Z, Bean L, Collins C, Khadilkar S, Gaitonde P, Dastur R, Wicklund M, Mozaffar T, Harms M, Rufibach L, Mittal P, Hegde M. Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients. Ann Clin Transl Neurol. 2018 Dec 1;5(12):1574-1587. doi: 10.1002/acn3.649. eCollection 2018 Dec.
- Poudel BH, Fletcher S, Wilton SD, Aung-Htut M. Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities. Int J Mol Sci. 2024 May 21;25(11):5572. doi: 10.3390/ijms25115572.
- Straub V, Murphy A, Udd B; LGMD workshop study group. 229th ENMC international workshop: Limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017. Neuromuscul Disord. 2018 Aug;28(8):702-710. doi: 10.1016/j.nmd.2018.05.007. Epub 2018 May 24. No abstract available.
- Thompson R, Straub V. Limb-girdle muscular dystrophies - international collaborations for translational research. Nat Rev Neurol. 2016 May;12(5):294-309. doi: 10.1038/nrneurol.2016.35. Epub 2016 Apr 1.
- Wicklund MP, Kissel JT. The limb-girdle muscular dystrophies. Neurol Clin. 2014 Aug;32(3):729-49, ix. doi: 10.1016/j.ncl.2014.04.005.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

